Site Map

• Home
• About Us
  • Operations Team
    • Prof Kausik Ray
    • Prof Neil Poulter
    • Dr Gaia Kiru
    • Dr Jennifer Murphy
    • Jessica Smith
    • Claire Brennan
    • Sima Toopchiani
    • Felicia Frost
    • Lisa Feng
  • Clinical Data Systems Team
    • Amanda Bravery
    • Francesco Lala
    • Abinithya Udayakumaran
    • Nayan Das
    • Smita Das
    • Zala Noorzad
    • Kayode Disu
    • Adina Ion
    • Dinesh Sivakumar
    • Tolulope Sokunle
    • Vivienne Okona-Mensah
  • Clinical Trial Statistics Team
    • Dr Graham Wheeler
    • Dr Suzie Cro
    • Jack Elkes
    • Emanuela Falaschetti
    • Dr Leila Janani
    • Nicholas Johnson
    • Matyas Szigeti
    • Ellie Van Vogt
    • Annie Wright
  • Quality Assurance Team
    • Eloise Britten
    • Jonathan Dao
  • Leadership
    • Prof Victoria Cornelius
    • Prof Kausik Ray
    • Prof Neil Poulter
    • Dr Daphne Babalis
    • Dr Gaia Kiru
    • Mrs Amanda Bravery
    • Ms Eloise Britten
    • Dr Suzie Cro
    • Dr Rachel Phillips
    • Dr Claire Smith
    • Ms Lauren Noto
  • Networks
• Services
  • Project Types
    • Drug/IMP Trials - All Phases
    • Observational Studies
    • Medical Device Trials
    • Evaluation of Diagnostic Tests
  • Clinical Trial Setup
    • Chief Investigator Input & Oversight
    • Protocol Design & Statistical Expertise
    • Regulatory & Ethics Submissions
    • Site Selection & Feasibility
  • Clinical Trial Delivery
    • Trial Management & Monitoring
    • Data Management
    • Close Out
    • Statistical Analysis
    • Publication & Dissemination
    • Education & Implementation
  • Quality and Compliance
  • Medical Education
    • Cardio-metabolic Dialogues
• Therapeutic Areas
  • Cardiovascular & Diabetes
  • Oncology
  • Infectious Disease & HIV
  • Surgery & Robotics
  • Respiratory
  • Emergency & Critical Care
  • Other Therapeutic Areas
• Clinical Data Systems
• Imperial News
  • ICTU Global Launch
  • COVID-19 vaccination cuts infection risk by half in school-aged children - REACT
  • UNEEG Medical Hyposafe System – An Exploratory Feasibility Study
  • First Site Initiated for GMRx2 ACT
  • GMRx2 ACT1 UK update
  • GMRx2 Placebo Controlled Trial (PCT)
• ICTU Global Insights
  • Our Global Reach
  • Our Recruitment Outcomes
  • Our Experience
• For the Public
  • About Clinical Trials
  • Steps Involved in a Study
  • Clinical Trial Phases
  • Medical Devices
  • FAQs
• Contact Us
• Terms & Conditions
• Privacy & Cookies